Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV003050579 | SCV003444378 | pathogenic | Charcot-Marie-Tooth disease axonal type 2Z | 2022-08-16 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 466 of the MORC2 protein (p.Asp466Asn). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with MORC2-related conditions (PMID: 27329773, 28334961). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. This variant is also known as c.1210G>A, D404N. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MORC2 protein function. For these reasons, this variant has been classified as Pathogenic. |